A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.
about
The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision makingGenome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancerSingle nucleotide polymorphisms in DNA repair genes as risk factors associated to prostate cancer progression.Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapyBiomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effectsGastrointestinal radiation injury: symptoms, risk factors and mechanismsSTROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics.A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer.Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients.Investigation of genetic polymorphisms related to the outcome of radiotherapy for prostate cancer patientsRadiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.Reducing rectal injury during external beam radiotherapy for prostate cancer.Recent advances in the management of radiation colitis.
P2860
Q27025062-59CD3BB8-86BF-4E81-A442-6C651B8E54CAQ28943357-91AF0A89-A25A-496E-BBA3-2824B552B3E6Q35046779-F709D684-77ED-4D2D-9CDA-A25607627075Q35084218-D645C2BC-B38E-4E59-A461-C6CBF4DED122Q36202850-03C09B92-F971-48D7-896B-97B256A3F390Q36541173-81055827-992A-4D04-93B5-F78E756EA949Q36672778-F341B524-8E10-442A-8789-46E7DBFE723DQ36699077-EF2E7923-7156-4930-8142-09746C272D7DQ37196316-6D6F56D8-9342-4CAC-9370-0DDC40F77A16Q37351439-16D6FF9D-FC12-4C35-A45D-3D153BC689FCQ37624254-CCB059F8-BD98-4B98-9113-864F528F70C5Q38106626-F8A1E467-EBCE-4F55-BB8E-76F4631E0443Q42641434-780B4FB6-5FCE-4CFC-825A-79BA52FB4D6C
P2860
A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
A genetically determined dose- ...... d with prostate brachytherapy.
@en
A genetically determined dose- ...... d with prostate brachytherapy.
@nl
type
label
A genetically determined dose- ...... d with prostate brachytherapy.
@en
A genetically determined dose- ...... d with prostate brachytherapy.
@nl
prefLabel
A genetically determined dose- ...... d with prostate brachytherapy.
@en
A genetically determined dose- ...... d with prostate brachytherapy.
@nl
P2093
P1476
A genetically determined dose- ...... d with prostate brachytherapy.
@en
P2093
Barry S Rosenstein
Christopher A Peters
David P Atencio
Jamie A Cesaretti
Nelson N Stone
Richard G Stock
Ryan J Burri
Sheila A Peters
P304
P356
10.1016/J.IJROBP.2007.02.052
P407
P577
2007-05-09T00:00:00Z